Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients

2017; Termedia Publishing House; Volume: 68; Issue: 3 Linguagem: Inglês

10.5114/pjp.2017.71532

ISSN

2084-9869

Autores

Irena Ćojbašić, Lana Mačukanović-Golubović, D. Mihailović, Miodrag Vučić, Žarko Ćojbašić,

Tópico(s)

Multiple Myeloma Research and Treatments

Resumo

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Ćojbašić I, Mačukanović-Golubović L, Mihailović D, Vučić M, Ćojbašić Ž. The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients. Polish Journal of Pathology. 2017;68(3):241-251. doi:10.5114/pjp.2017.71532. APA Ćojbašić, I., Mačukanović-Golubović, L., Mihailović, D., Vučić, M., & Ćojbašić, Ž. (2017). The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients. Polish Journal of Pathology, 68(3), 241-251. https://doi.org/10.5114/pjp.2017.71532 Chicago Ćojbašić, Irena, Lana Mačukanović-Golubović, Dragan Mihailović, Miodrag Vučić, and Žarko Ćojbašić. 2017. "The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients". Polish Journal of Pathology 68 (3): 241-251. doi:10.5114/pjp.2017.71532. Harvard Ćojbašić, I., Mačukanović-Golubović, L., Mihailović, D., Vučić, M., and Ćojbašić, Ž. (2017). The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients. Polish Journal of Pathology, 68(3), pp.241-251. https://doi.org/10.5114/pjp.2017.71532 MLA Ćojbašić, Irena et al. "The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients." Polish Journal of Pathology, vol. 68, no. 3, 2017, pp. 241-251. doi:10.5114/pjp.2017.71532. Vancouver Ćojbašić I, Mačukanović-Golubović L, Mihailović D, Vučić M, Ćojbašić Ž. The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients. Polish Journal of Pathology. 2017;68(3):241-251. doi:10.5114/pjp.2017.71532.

Referência(s)